1100058

Kite Pharma, Inc. — FEI 3012583739

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 20, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
El Segundo, CA (United States)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
189021 CFR 211.165(e)Test methods
908921 CFR 600.14(c)When to report